Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
Authors:ID Smole, Anže (Author)
ID Benton, Alexander (Author)
ID Poussin, Mathilde A. (Author)
ID Eiva, Monika A. (Author)
ID Mezzanotte, Claudia (Author)
Files:URL URL - Source URL, visit https://doi.org/10.1016/j.ccell.2022.11.006
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo NIB - National Institute of Biology
Abstract:Despite the success of CAR-T cell cancer immunotherapy, challenges in efficacy and safety remain. Investigators have begun to enhance CAR-T cells with the expression of accessory molecules to address these challenges. Current systems rely on constitutive transgene expression or multiple viral vectors, resulting in unregulated response and product heterogeneity. Here, we develop a genetic platform that combines autonomous antigen-induced production of an accessory molecule with constitutive CAR expression in a single lentiviral vector called Uni-Vect. The broad therapeutic application of Uni-Vect is demonstrated in vivo by activation-dependent expression of (1) an immunostimulatory cytokine that improves efficacy, (2) an antibody that ameliorates cytokine-release syndrome, and (3) transcription factors that modulate T cell biology. Uni-Vect is also implemented as a platform to characterize immune receptors. Overall, we demonstrate that Uni-Vect provides a foundation for a more clinically actionable next-generation cellular immunotherapy.
Keywords:CAR-T cells, TCR, inducible, transcription factor, NFAT, single lentiviral expression system, IL-6, IL-12, CRS, armored
Publication status:Published
Publication version:Preprint, working version of publication, not peer-reviewed
Publication date:12.12.2022
Year of publishing:2022
Number of pages:str. 1470-1487, e1-e7
Numbering:Vol. 40, iss. 12
PID:20.500.12556/DiRROS-19389 New window
UDC:616-006
ISSN on article:1535-6108
DOI:10.1016/j.ccell.2022.11.006 New window
COBISS.SI-ID:134077187 New window
Note:Ostali avtorji: Alexander Benton, Mathilde A. Poussin, Monika A. Eiva, Claudia Mezzanotte, Barbara Camisa, Beatrice Greco, Prannda Sharma, Nicholas G. Minutolo, Falon Gray, Adham S. Bear, Miren L. Baroja, Casey Cummins, Chong Xu, Francesca Sanvito, Andrea Lang Goldgewicht, Tatiana Blanchard, Alba Rodriguez-Garcia, Michael Klichinsky, Chiara Bonini, Carl H. June, Avery D. Posey Jr., Gerald P. Linette, Beatriz M. Carreno, Monica Casucci, Daniel J. Powell Jr.;
Publication date in DiRROS:18.07.2024
Views:5
Downloads:2
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Cancer cell
Shortened title:Cancer cell
Publisher:Cell Press
ISSN:1535-6108
COBISS.SI-ID:18246439 New window

Document is financed by a project

Funder:EC - European Commission
Project number:754658
Name:SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease
Acronym:CARAMBA

Funder:EC - European Commission
Project number:945393
Name:Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy
Acronym:T2EVOLVE

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-3084-2021
Name:Inducibilno Programiranje Intrinzičnih Lastnosti Celic CAR T za Imunoterapijo Raka

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0245-2019
Name:Ekotoksiologija, toksikološka genomika in karcinogeneza

Funder:Other - Other funder or multiple funders
Funding programme:Parker Institute for Cancer Immunotherapy (PICI)
Project number:R01EB026892, R21CA205794, and R01CA204261

Funder:Other - Other funder or multiple funders
Funding programme:pharmacology T32 training grant
Project number:T32GM008076

Funder:Other - Other funder or multiple funders
Funding programme:funding from AIRC
Project number:IG 18458 and IG 2020 ID 24965

Funder:Other - Other funder or multiple funders
Funding programme:Italian Ministry of Research and University
Project number:PRIN 2017WC8499

Funder:Other - Other funder or multiple funders
Funding programme:Italian Ministry of Health
Project number:RCR-2019-23669115
Name:Ricerca Corrente CAR-T project

Funder:Other - Other funder or multiple funders
Funding programme:AIRC
Project number:22737

Funder:Other - Other funder or multiple funders
Funding programme:Research fund of the National Institute of Biology
Acronym:10ICIGEN

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:celice CAR-T, celična imunoterapija, rak, gensko spremenjene imunske celice, urejanje genoma, onkologija, citologija, genomika


Back